Evidence map›Paper›PMID 38527430›Full record

ArticleCardiology2024

Balloon Aortic Valvuloplasty with or without Percutaneous Coronary Intervention in the Transcatheter Aortic Valve Replacement Era.

Omar Aldalati, Matthew Jackson, Seth Vijayan, Pyotr Telyuk, Umair Hayat, Shaza Bashir, Sharareh Vahabi, Gemma McCalmont, Mark A de Belder, Douglas Muir and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Omar AldalatiCardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.
Matthew JacksonCardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.
Seth VijayanCardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.
Pyotr TelyukCardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.
Umair HayatCardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.
Shaza BashirCardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.
Sharareh VahabiCardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.
Gemma McCalmontCardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.
Mark A de BelderCardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.
Douglas MuirCardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.
Paul D WilliamsCardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe role of balloon aortic valvuloplasty (BAV) in the era of transcatheter aortic valve replacement remains a topic of debate. We sought to study the safety and feasibility of combined BAV and percutaneous coronary intervention (BAV-PCI).

methodsBetween November 2009 and July 2020, all patients undergoing BAV were identified and divided into three groups: combined BAV-PCI (group A), BAV with significant unrevascularised CAD (group B), and BAV without significant CAD (group C). Procedural outcomes and 30-day and one-year mortality were compared.

resultsA total of 264 patients were studied (n = 84, 93, and 87 patients in groups A, B, and C, respectively). The STS score was 10.2 ± 8, 13.3 ± 19, and 8.1 ± 7, p = 0.026, in groups A, B, and C, respectively. VARC-3 adjudicated complications were similar among groups (11%, 13%, and 5%, respectively, p = 0.168, respectively). Thirty-day and one-year mortality were 9.8% (n = 26) and 32% (n = 86) of the entire cohort. The differences among groups did not reach statistical significance. Using univariate Cox regression analysis, group B patients were at higher risk of dying compared to group A patients (HR 1.58, 95% CI: 1.11-2.25, p = 0.010). With multivariate Cox regression analysis, the predictors of mortality were STS score, cardiogenic shock, mode of presentation, and lack of subsequent definitive valve intervention.

conclusionIn high-risk patients with aortic valve stenosis, combined BAV-PCI is safe and feasible with comparable outcomes to BAV with and without significant CAD.

Indexed as

Aortic Valve StenosisBalloon ValvuloplastyPercutaneous Coronary InterventionTranscatheter Aortic Valve ReplacementAgedAged, 80 and overCoronary Artery DiseaseFeasibility StudiesFemaleHumansMaleRetrospective StudiesTreatment OutcomeAcute coronary syndromeAortic valve stenosisBalloon aortic valvuloplastyCombined proceduresPercutaneous coronary intervention

Identifiers

PMID38527430
PMCPMC11449180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.